about
Long-term treatment of thrombosis with enoxaparin in pediatric and adolescent patients.Safety and efficacy of danaparoid (Orgaran) use in children.Current and future antithrombotic agents in children.Pharmacokinetics, efficacy, and safety of LMWHs in venous thrombosis and stroke in neonates, infants and childrenA practical approach to the use of low molecular weight heparins in VTE treatment and prophylaxis in children and newborns.Association of outcomes and anti-Xa levels in the treatment of pediatric venous thromboembolism.Outcomes using a clinical practice pathway for the management of pulse loss following pediatric cardiac catheterization.Anti-Xa stability of diluted enoxaparin for use in pediatrics.
P2860
Q33370613-5DC657E8-0E37-4BF0-9EEE-84F2B1B8E4F3Q33370615-6CBC00AA-1EA5-4D26-80E7-19661515BF41Q35821894-EA80B147-EE8D-429D-A757-4D36FED7B126Q36510063-630E7344-A5BE-4743-AB73-69F2DB20524DQ38261097-4111F7D5-A57F-4801-BCEA-E7B432FFD6A8Q38776899-7E26C4E4-1C55-41A7-95B0-B0D399D0F2CFQ44175027-3A1F7CF2-E788-4639-88E8-37ED84ADF517Q44776121-ADD02EF0-83F3-46EF-B4B9-29B4DD656B62
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Low molecular weight heparin in children.
@ast
Low molecular weight heparin in children.
@en
type
label
Low molecular weight heparin in children.
@ast
Low molecular weight heparin in children.
@en
prefLabel
Low molecular weight heparin in children.
@ast
Low molecular weight heparin in children.
@en
P1476
Low molecular weight heparin in children.
@en
P2093
Manuela Albisetti
Maureen Andrew
P2888
P356
10.1007/S00431-001-0873-9
P577
2002-02-01T00:00:00Z
P6179
1049337803